DaVita Closes Deal to Provide Dialysis Services in Taiwan

Sun Jan 20, 2013 5:00pm EST

* Reuters is not responsible for the content in this press release.


Deal Marks Entry into Taiwan
DENVER & TAIPEI, Taiwan--(Business Wire)--
DaVita, the kidney care division of DaVita HealthCare Partners Inc. (NYSE: DVA)
and a leading provider of kidney care services, today announced the formation of
a joint venture with Riches Healthcare (RHC), through which a new entity -
DaVita Taiwan - will provide services to four dialysis clinics. DaVita will own
a majority share of the joint venture entity. 

"Expanding our presence into Taiwan is a key step in our long-term growth
strategy in Asia," said Dennis Kogod, chief operating officer at DaVita. 

The four clinics currently serviced by RHC are located in and around Taipei,
have a combined number of 88 stations and are providing hemodialysis treatments
to more than 250 patients. 

"This acquisition is an exciting opportunity not only to expand into Taiwan, but
also to do so with a well-respected and highly experienced team," said Atul
Mathur, president of Asia Pacific at DaVita. "With the addition of this JV,
DaVita is now serving patients in five countries across the Asia Pacific

As a leading provider of kidney care services in the United States, DaVita has
achieved clinical outcomes that have improved year-over-year for more than a
decade and plans to bring that track record of sustained clinical excellence to

For more information on DaVita please visit www.DaVita.com. 

DaVita is a registered trademark, and DaVita HealthCare Partners is a service
mark, of DaVita HealthCare Partners Inc. All other marks are the property of
their respective owners. 

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune
500 company. A leading provider of kidney care in the United States, DaVita
delivers dialysis services to patients with chronic kidney failure and end stage
renal disease. DaVita strives to improve patients` quality of life by innovating
clinical care, and by offering integrated treatment plans, personalized care
teams and convenient health-management services. As of Sept. 30, 2012, DaVita
operated or provided administrative services at 1,912 outpatient dialysis
centers located in the United States serving approximately 150,000 patients. The
company also operated 24 outpatient dialysis centers located in five countries
outside the United States. DaVita supports numerous programs dedicated to
creating positive, sustainable change in communities around the world. The
company`s leadership development initiatives and social responsibility efforts
have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. 

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the
federal securities laws, including statements related to prospective near-term
and long-term growth, development, strategy and expectations for certain of our
international operations, anticipated patient benefits and projected clinical
outcomes. Factors which could impact future results include the risks and
uncertainties associated with expansion of our operations and services to
markets outside the United States, local laws and regulations, general economic
and other market conditions, competition, and the risk factors set forth in our
SEC filings, including our Annual Report on Form 10-K for the year ended
December 31, 2011, and our subsequently filed Quarterly Reports on Form 10-Q.
The forward-looking statements should be considered in light of these risks and
uncertainties. We base our forward-looking statements on information currently
available to us at the time of this release, and we undertake no obligation to
update or revise any forward-looking statements, whether as a result of changes
in underlying factors, new information, future events or otherwise.

Skip Thurman, 303-876-6610
Mobile: 720-300-0041

Copyright Business Wire 2013

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.